Epidemiology of Primary Hyperparathyroidism

Robert A. Wermers, Bart Clarke

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

After the introduction of automated chemistry panels, including the routine measurement of serum calcium, there was a dramatic rise in the incidence of primary hyperparathyroidism (PHPT) in the early 1970s. In addition, the clinical spectrum shifted from complicated symptomatic to uncomplicated asymptomatic disease. After the initial identification of previously unrecognized cases, the incidence rate fell and continued to decline until the middle to late 1990s when the incidence once again increased for uncertain reasons. Postmenopausal women have the highest incidence rate of PHPT and blacks also appear to have a greater risk. Conflicting information exists regarding death in patients with PHPT, with North American data not demonstrating increased mortality compared to European populations, where survival is reduced. Although current cost-effectiveness studies of surgery versus observation of asymptomatic PHPT are limited by the lack of long-term randomized data, available information suggests that surgery benefit exceeds cost after 5-6 years.

Original languageEnglish (US)
Title of host publicationThe Parathyroids
Subtitle of host publicationBasic and Clinical Concepts: Third Edition
PublisherElsevier Inc.
Pages297-308
Number of pages12
ISBN (Print)9780123971661
DOIs
StatePublished - Sep 5 2014

Fingerprint

Primary Hyperparathyroidism
Epidemiology
Incidence
Cost-Benefit Analysis
Asymptomatic Diseases
Observation
Calcium
Survival
Mortality
Serum
Population

Keywords

  • Cost
  • Epidemiology
  • Estrogen
  • Hydrochlorothiazide
  • Incidence
  • Lithium
  • Mortality
  • Prevalence
  • Primary hyperparathyroidism
  • Symptoms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wermers, R. A., & Clarke, B. (2014). Epidemiology of Primary Hyperparathyroidism. In The Parathyroids: Basic and Clinical Concepts: Third Edition (pp. 297-308). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397166-1.00019-9

Epidemiology of Primary Hyperparathyroidism. / Wermers, Robert A.; Clarke, Bart.

The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. p. 297-308.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wermers, RA & Clarke, B 2014, Epidemiology of Primary Hyperparathyroidism. in The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., pp. 297-308. https://doi.org/10.1016/B978-0-12-397166-1.00019-9
Wermers RA, Clarke B. Epidemiology of Primary Hyperparathyroidism. In The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc. 2014. p. 297-308 https://doi.org/10.1016/B978-0-12-397166-1.00019-9
Wermers, Robert A. ; Clarke, Bart. / Epidemiology of Primary Hyperparathyroidism. The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. pp. 297-308
@inbook{9c40bf9797ca4047bb51520320952a66,
title = "Epidemiology of Primary Hyperparathyroidism",
abstract = "After the introduction of automated chemistry panels, including the routine measurement of serum calcium, there was a dramatic rise in the incidence of primary hyperparathyroidism (PHPT) in the early 1970s. In addition, the clinical spectrum shifted from complicated symptomatic to uncomplicated asymptomatic disease. After the initial identification of previously unrecognized cases, the incidence rate fell and continued to decline until the middle to late 1990s when the incidence once again increased for uncertain reasons. Postmenopausal women have the highest incidence rate of PHPT and blacks also appear to have a greater risk. Conflicting information exists regarding death in patients with PHPT, with North American data not demonstrating increased mortality compared to European populations, where survival is reduced. Although current cost-effectiveness studies of surgery versus observation of asymptomatic PHPT are limited by the lack of long-term randomized data, available information suggests that surgery benefit exceeds cost after 5-6 years.",
keywords = "Cost, Epidemiology, Estrogen, Hydrochlorothiazide, Incidence, Lithium, Mortality, Prevalence, Primary hyperparathyroidism, Symptoms",
author = "Wermers, {Robert A.} and Bart Clarke",
year = "2014",
month = "9",
day = "5",
doi = "10.1016/B978-0-12-397166-1.00019-9",
language = "English (US)",
isbn = "9780123971661",
pages = "297--308",
booktitle = "The Parathyroids",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Epidemiology of Primary Hyperparathyroidism

AU - Wermers, Robert A.

AU - Clarke, Bart

PY - 2014/9/5

Y1 - 2014/9/5

N2 - After the introduction of automated chemistry panels, including the routine measurement of serum calcium, there was a dramatic rise in the incidence of primary hyperparathyroidism (PHPT) in the early 1970s. In addition, the clinical spectrum shifted from complicated symptomatic to uncomplicated asymptomatic disease. After the initial identification of previously unrecognized cases, the incidence rate fell and continued to decline until the middle to late 1990s when the incidence once again increased for uncertain reasons. Postmenopausal women have the highest incidence rate of PHPT and blacks also appear to have a greater risk. Conflicting information exists regarding death in patients with PHPT, with North American data not demonstrating increased mortality compared to European populations, where survival is reduced. Although current cost-effectiveness studies of surgery versus observation of asymptomatic PHPT are limited by the lack of long-term randomized data, available information suggests that surgery benefit exceeds cost after 5-6 years.

AB - After the introduction of automated chemistry panels, including the routine measurement of serum calcium, there was a dramatic rise in the incidence of primary hyperparathyroidism (PHPT) in the early 1970s. In addition, the clinical spectrum shifted from complicated symptomatic to uncomplicated asymptomatic disease. After the initial identification of previously unrecognized cases, the incidence rate fell and continued to decline until the middle to late 1990s when the incidence once again increased for uncertain reasons. Postmenopausal women have the highest incidence rate of PHPT and blacks also appear to have a greater risk. Conflicting information exists regarding death in patients with PHPT, with North American data not demonstrating increased mortality compared to European populations, where survival is reduced. Although current cost-effectiveness studies of surgery versus observation of asymptomatic PHPT are limited by the lack of long-term randomized data, available information suggests that surgery benefit exceeds cost after 5-6 years.

KW - Cost

KW - Epidemiology

KW - Estrogen

KW - Hydrochlorothiazide

KW - Incidence

KW - Lithium

KW - Mortality

KW - Prevalence

KW - Primary hyperparathyroidism

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=84942776629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942776629&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-397166-1.00019-9

DO - 10.1016/B978-0-12-397166-1.00019-9

M3 - Chapter

AN - SCOPUS:84942776629

SN - 9780123971661

SP - 297

EP - 308

BT - The Parathyroids

PB - Elsevier Inc.

ER -